|
Topics in Evidence-Based Pharmacy Practice
10/13/2010: Microvascular Complications in Type 2 Diabetes: Intensive vs. Standard Therapy
Michael Farquhar
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Veronica Alaniz
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Elizabeth G. Montfort
Feik School of Pharmacy, University of the Incarnate Word, San Antonio, Texas
Excerpt:"Diabetes is emerging as a leading cause of morbidity and mortality. The total number of people in the world with diabetes is projected to rise from 171 million in 2000 to 366 million in 2030.1 The quality of life in diabetic subjects is often worsened by the presence of microvascular complications such as neuropathy, nephropathy, retinopathy, and cataracts.2 Analysis of available epidemiological evidence suggests that hyperglycemia is an important contributor to development and progression of microvascular complications in type 2 diabetes.3..."
|
|
|
|
|